We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

9 Jul 2020 07:00

RNS Number : 4605S
Science in Sport PLC
09 July 2020
 

 

9 July 2020

 

 

 

SCIENCE IN SPORT PLC

("Company" or "Group")

Half Year Trading Update and Notice of Results

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, is pleased to announce its pre-close trading statement for the six months to 30 June 2020.

 

Contingency plans were enacted in early March to deal with the COVID-19 pandemic, including significant cost reductions, together with an equity raise in April. Changing consumer behaviour has accelerated our shift to online channels, and we have done this while improving margins.

 

Our USA business has been streamlined and has continued to grow strongly while sharply reducing cash consumption. Export Retail delivered growth in a challenging environment, and the first signs of increased activity in UK Retail channels are now apparent. Supply chain efficiencies continue to drive improved gross margin.

 

Group revenue for the period was £23.6m, down 5% on last year (H1 2019: £24.9m) reflecting the severe Q2 disruption caused in all markets by the COVID-19 pandemic. Science in Sport delivered revenue of £11.9m, down 5% (H1 2019: £12.5m) while PhD delivered £11.7m, down 6% on 2019 (H1 2019: £12.4m).

 

Online channels performed very strongly. Our E-Commerce platform delivered revenues of £6.0m across all markets, 27% ahead of 2019. Amazon was 22% ahead, with revenues of £4.1m. Online accounted for 42% of total business at the end of H1, up from 32% in 2019.

 

Export Retail delivered revenue of £5.8m, 2% up (H1 2019: £5.7m) in challenging conditions. UK Retail has seen the hardest downturn from the COVID-19 lockdown and £7.7m revenue is 31% below last year (2019: £11.2m). We are seeing some increase in demand and are cautiously optimistic.

 

USA delivered revenue of £1.5m, 30% ahead of last year. Robust growth was delivered in Amazon and the SiS.com platform. We expect a significantly reduced EBITDA loss in the USA, given substantial progress from a leaner cost base.

 

Sales from new products were £1.4m for the period, 8% ahead of the corresponding number in 2019. PhD Smart Plant and PhD Smart Cakes delivered £1m of the total. A strong pipeline will drive revenue for both brands in the second half.

 

Supply chain synergies in operations and purchasing, together with margin improvement from E-Commerce resulted in gross margin of 47.7% which is 290bps ahead of last year (H1 2019: 44.8%).

 

Given improved margins and reduced costs, together with a £4.5m gross equity raise, net cash is strong, with approximately £9.0m at hand. We also secured a flexible £8m debt facility with HSBC, which remains unused. Inventory was £6.9m, compared with £8.6m in 2019, and we expect to lower it further in H2.

 

Management focus is on delivery of the long-term strategy, which is underpinned by science-led innovation, investment in brand equity, focus on online channels and growth in global markets. A new gel machine will commission in late 2021, and we are assessing the supply chain footprint intending to improve service while reducing internal logistics costs.

 

While the outlook remains uncertain, and the Board believes it is too early to reinstate financial guidance, the strategic drivers of the business remain strong. We expect to return the business to its proven growth trajectory as and when the pandemic abates.

 

The Company will announce its interim results for the period ended 30 June 2020 on Wednesday 16 September 2020.

 

For further information:

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

LiberumNominated adviser and broker

Bidhi BhomaJames GreenwoodWill Hall

+44 (0) 20 3100 2000

 

Notes to Editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium protein brand targeting gym lifestyle and sports enthusiasts, and SiS, a leading brand among elite athletes and professional sports teams.

The two brands are sold internationally through multiple retail channels, both traditional and online, including major supermarkets and high street chains, specialist sports retailers and e-commerce sites including Amazon and the brands' websites. They enable the Company to address the full breadth of the performance nutrition market currently estimated at approximately £10 billion worldwide.

PhD is one of the UK's leading protein brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since its launch in 2005. The range now comprises powders, bars, flapjacks, drinks and other products including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include endurance athlete Ross Edgley, WBA international champion Jordan Gill, Team GB Olympic sprinter Asha Philip and leading fitness influencer Obi Vincent. The PhD brand is an official partner to the Tough Mudder Challenge and Race Series.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and endurance. SiS is the official sports nutrition supplier to many professional teams and organisations including Team INEOS Cycling, Team Ineos UK (America's Cup Team), British Cycling, Cycling Australia, USA Cycling and USA Triathlon. SiS supplies more than 100 professional football clubs in the UK, Europe and USA, and is an official partner Manchester United Football. SiS brand ambassadors include Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFITDFITIII
Date   Source Headline
6th Mar 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDirector/PDMR Shareholding
5th Jan 20247:00 amRNSNotification of Major Holdings
29th Dec 202311:20 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSDirectorate Change
16th Oct 20237:00 amRNSBoard Changes
28th Sep 202310:30 amRNSInterim Results - Replacement
28th Sep 20237:00 amRNSAppointment of Non Exec Chairman
28th Sep 20237:00 amRNSInterim Results
28th Jul 20232:58 pmRNSResult of Annual General Meeting
28th Jul 20237:00 amRNSBoard changes
10th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20233:49 pmRNSTR-1: Notification of Major Holdings
5th Jul 20237:00 amRNSBoard Change and Notice of AGM
4th Jul 20237:30 amRNSRestoration - Science in Sport PLC
4th Jul 20237:00 amRNSRestoration of Trading & Posting of Annual Report
3rd Jul 20237:30 amRNSSuspension - Science In Sport Plc
3rd Jul 20237:00 amRNSTemporary Suspension
29th Jun 202310:38 amRNSReplacement RNS - Preliminary Results
29th Jun 20237:00 amRNSFinal results
28th Jun 202310:43 amRNSNotification of Major Holdings
23rd Jun 20237:00 amRNSNotice of Final Results
2nd May 20233:33 pmRNSAIM Rule 17 / Schedule 2(g) Update
18th Apr 20237:00 amRNSInvestor Site Visit
13th Apr 202312:23 pmRNSForm 8.3 - Science In Sport Plc
13th Apr 202312:06 pmRNSForm 8.3 - Science in Sport PLC
13th Apr 20238:34 amRNSForm 8.5 (EPT/RI)
13th Apr 20237:00 amRNSConclusion of Strategic Review and Trading Update
12th Apr 20239:06 amRNSForm 8.5 (EPT/RI)
11th Apr 20232:54 pmRNSForm 8.3 - Science In Sport Plc
11th Apr 202312:17 pmRNSForm 8.3 - Science in Sport PLC
11th Apr 20239:22 amRNSForm 8.5 (EPT/RI)
11th Apr 20237:00 amRNSForm 8.3 - Science in Sport PLC
6th Apr 20236:17 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
6th Apr 20232:52 pmRNSForm 8.3 - [Science in Sport plc]
5th Apr 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Apr 20232:29 pmRNSForm 8.3 - [Science in Sport plc]
3rd Apr 20239:20 amRNSForm 8.5 (EPT/RI)
30th Mar 20238:50 amRNSForm 8.5 (EPT/RI)
29th Mar 202311:58 amRNSForm 8.3 - Science in Sport Plc
29th Mar 20238:42 amRNSForm 8.5 (EPT/RI)
28th Mar 20239:57 amRNSForm 8.3 - Science in Sport Plc
28th Mar 20239:52 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
27th Mar 202312:31 pmRNSForm 8.3 - Science in Sport PLC
27th Mar 202312:29 pmRNSForm 8.3 - Science in Sport Plc
23rd Mar 202311:01 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 202310:54 amRNSForm 8.3 - Science in Sport PLC
23rd Mar 20238:43 amRNSForm 8.5 (EPT/RI)
22nd Mar 20235:55 pmRNSForm 8.3 - Science in Sport PLC
22nd Mar 20231:15 pmRNSForm 8.3 - Science in Sport plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.